Hennessy Capital VIII Launches $175M SPAC IPO Targeting Energy Transition

TL;DR

**Avoid this SPAC; the founder share structure and potential dilution heavily favor insiders, making it a risky bet for public investors.**

AI Summary

Hennessy Capital Investment Corp. VIII (HCICU) filed an S-1 on December 3, 2025, for an initial public offering of 17,500,000 units at $10.00 per unit, aiming to raise $175,000,000. Each unit comprises one Class A ordinary share and one right to receive one-fifteenth (1/15) of a Class A ordinary share upon business combination. The SPAC intends to target companies in the industrial innovation and energy transition sectors. The sponsor, Hennessy Capital Investment Corp. VIII, purchased 8,910,429 Class B ordinary shares for a nominal price of $25,000, or approximately $0.003 per share, leading to significant potential dilution for public shareholders. Additionally, the sponsor and Cohen & Company subscribed for 560,500 private placement units at $10.00 each, totaling $5,605,000. The company will deposit $175,000,000 into a U.S.-based trust account and has 24 months to complete an initial business combination. Management and the sponsor will receive monthly fees totaling at least $40,000 for office space and services, and up to $2.5 million in working capital loans from the sponsor may be convertible into private placement units.

Why It Matters

This S-1 filing signals Hennessy Capital Investment Corp. VIII's entry into the SPAC market, aiming to capitalize on the growing industrial innovation and energy transition sectors. For investors, the offering structure, which excludes warrants but includes Share Rights, differs from many SPACs, potentially altering risk-reward profiles. The significant dilution from the sponsor's founder shares, acquired at $0.003 per share, is a critical factor for prospective public shareholders, as is the 30.1% anti-dilution protection for founder shares. The competitive landscape for SPACs targeting these sectors is intense, meaning HCICU faces pressure to identify a high-quality target within its 24-month window.

Risk Assessment

Risk Level: high — The S-1 explicitly states that the sponsor paid a nominal price of approximately $0.003 per founder share, leading to "immediate and substantial dilution" for public shareholders. Furthermore, the Class B ordinary shares' anti-dilution rights could result in a conversion ratio greater than one-to-one, potentially diluting public shareholders' interests by up to 30.1% of the post-combination entity, which is higher than the typical 20% in similar blank check companies.

Analyst Insight

Investors should exercise extreme caution and thoroughly evaluate the significant dilution risks associated with the founder shares and their anti-dilution provisions. Consider waiting until a definitive business combination target is announced and the full financial implications of the founder share conversion are clear before investing in HCICU.

Financial Highlights

revenue

$0

operating Margin

N/A

total Assets

$175,000,000

total Debt

$0

net Income

$0

eps

$0.00

gross Margin

N/A

cash Position

$175,000,000

revenue Growth

N/A

Key Numbers

• $175,000,000 — Total offering price (Amount to be raised in the IPO and deposited into the trust account)
• 17,500,000 — Units offered (Number of units available in the initial public offering)
• $10.00 — Price per unit (Offering price for each unit in the IPO)
• 8,910,429 — Founder shares (Number of Class B ordinary shares purchased by the sponsor)
• $0.003 — Price per founder share (Nominal purchase price paid by the sponsor for Class B ordinary shares)
• 24 months — Completion window (Time period to consummate an initial business combination)
• 30.1% — Founder share conversion ratio (Maximum percentage of Class A ordinary shares issuable upon conversion of Class B ordinary shares, potentially diluting public shareholders)
• $5,605,000 — Private placement units total purchase price (Aggregate amount paid by sponsor and Cohen & Company for private placement units)
• $15,000 — Monthly payment for office space (Amount paid to an affiliate of the sponsor for office space, utilities, and administrative support)
• $250,000 — Sponsor loan repayment (Maximum amount of loans from the sponsor to be repaid upon offering consummation)

Key Players & Entities

• Hennessy Capital Investment Corp. VIII (company) — Registrant and SPAC
• Daniel J. Hennessy (person) — Chairman and Chief Executive Officer
• Nicholas Geeza (person) — Executive Vice President, Chief Financial Officer and Secretary
• Thomas D. Hennessy (person) — President
• Barclays Capital Inc. (company) — Underwriter
• Cohen & Company Capital Markets (company) — Deferred Underwriter and private placement subscriber
• Odyssey Transfer and Trust Company (company) — Trustee for the trust account
• Hennessy Capital Group LLC (company) — Affiliate of sponsor receiving monthly payments
• SEC (regulator) — Securities and Exchange Commission
• Nasdaq Global Market (company) — Intended listing exchange

FAQ

Risk Factors

• Lack of Operating History [high — financial]: HCICU has no operating history and no revenues. The company has a limited history of operations and is subject to all the risks and uncertainties associated with a new enterprise. Its ability to generate future revenue is dependent on the successful completion of a business combination and the subsequent performance of the target business.
• Dependence on Sponsor and Management Team [high — financial]: The success of HCICU is substantially dependent upon the expertise and diligence of its sponsor, Hennessy Capital Management, LLC, and its management team. Their ability to identify and complete a suitable business combination, and to manage the target business post-combination, is critical. Any failure in their performance could materially and adversely affect the company.
• Potential Dilution from Sponsor Shares and Warrants [high — financial]: The sponsor holds 8,910,429 Class B ordinary shares, which are convertible into Class A ordinary shares on a 1:1 basis, subject to adjustments. Additionally, private placement units and potential conversion of working capital loans into private placement units can further dilute public shareholders. The conversion of these securities could result in significant dilution.
• Competition for Business Combinations [medium — market]: HCICU operates in a highly competitive market for identifying and acquiring suitable businesses. Many other SPACs are also seeking to complete business combinations, which may increase the difficulty of finding an attractive target and may drive up the purchase price, potentially impacting the returns for public shareholders.
• Regulatory Scrutiny of SPACs [medium — regulatory]: The SPAC market has faced increasing regulatory scrutiny. Changes in regulations or accounting standards related to SPACs could impact HCICU's ability to complete a business combination or the terms thereof, potentially affecting its valuation and investor confidence.
• Redemption Risk [medium — financial]: Public shareholders have the right to redeem their shares for a pro rata portion of the trust account if they do not approve of the business combination. A high redemption rate could reduce the amount of capital available for the combined company, potentially hindering its growth prospects and ability to execute its business plan.
• Failure to Complete a Business Combination [high — operational]: HCICU has a limited timeframe of 24 months to complete a business combination. If it fails to do so, it will liquidate and dissolve, and the proceeds held in the trust account will be returned to public shareholders. This failure would result in a loss of the investment for shareholders and the forfeiture of the sponsor's founder shares.
• Working Capital Loan Conversion [medium — financial]: The sponsor may provide up to $2.5 million in working capital loans, which may be convertible into private placement units. The terms of this conversion could lead to additional dilution for public shareholders if not structured favorably.

Industry Context

The industrial innovation and energy transition sectors are experiencing significant investment driven by global decarbonization efforts and technological advancements. Companies in these areas often require substantial capital for research, development, and scaling operations. The competitive landscape includes established players and numerous emerging companies, with SPACs like HCICU seeking to capitalize on this growth by providing access to public markets.

Regulatory Implications

The Securities and Exchange Commission (SEC) continues to scrutinize SPAC transactions, focusing on disclosures, projections, and potential conflicts of interest. HCICU must ensure robust compliance with evolving regulations, particularly concerning the valuation of target companies and the disclosure of sponsor economics to protect investors and facilitate a successful business combination.

What Investors Should Do

1. Review Sponsor Economics and Dilution
2. Evaluate Target Sector Focus
3. Monitor Deal Pipeline and Timeline
4. Understand Redemption Rights

Key Dates

• 2025-12-03: S-1 Filing — Initiated the IPO process, providing initial details on the offering structure, target sectors, and sponsor economics.

Glossary

SPAC

Special Purpose Acquisition Company. A shell company that is formed to raise capital through an initial public offering (IPO) for the purpose of acquiring or merging with an existing company. (HCICU is a SPAC, and its primary purpose is to find and merge with a target company.)

Units

In a SPAC IPO, units typically consist of one ordinary share and a fraction of a warrant or right to purchase an additional share. (HCICU is offering units, each comprising a Class A ordinary share and 1/15th of a Class A ordinary share upon business combination.)

Class B Ordinary Shares

Shares typically held by the SPAC sponsor, which usually convert into Class A ordinary shares upon a business combination and often carry voting rights. (The sponsor holds Class B shares, which are subject to conversion and potential dilution for public shareholders.)

Trust Account

A segregated account where the proceeds from a SPAC's IPO are held until a business combination is completed or the SPAC liquidates. (The $175,000,000 raised in the IPO will be deposited into a trust account.)

Business Combination

The acquisition or merger of a SPAC with a target operating company. (HCICU has 24 months to identify and complete a business combination.)

Founder Shares

Shares typically issued to the SPAC sponsor at a nominal price, often convertible into Class A shares and subject to vesting or other conditions. (The sponsor's Class B shares are effectively founder shares, purchased at a nominal price.)

Private Placement Units

Units purchased by the sponsor or other strategic investors concurrently with the IPO, often at the same unit price, but without the same redemption rights as public shareholders. (The sponsor and Cohen & Company purchased private placement units, which can impact overall dilution.)

Rights

A security that gives the holder the right, but not the obligation, to purchase a security (in this case, Class A ordinary shares) at a specified price within a specified time period. (Each unit includes a right to receive 1/15th of a Class A ordinary share upon business combination.)

Year-Over-Year Comparison

As this is an initial S-1 filing for Hennessy Capital Investment Corp. VIII, there is no prior year filing to compare against. Key metrics such as revenue, net income, and margins are not applicable at this pre-IPO stage. The primary focus is on the offering structure, the capital to be raised ($175,000,000), the sponsor's economics, and the identified risks associated with SPACs and the target industries.

Key Financial Figures

• $175,000,000 — MBER 3, 2025 PRELIMINARY PROSPECTUS $175,000,000 Hennessy Capital Investment Corp. VII
• $10.00 — ies. Each unit has an offering price of $10.00 and consists of one Class A ordinary sh
• $100,000 — (net of permitted withdrawals and up to $100,000 of interest to pay dissolution expenses
• $0.20 — $ 9.60 $ 168,000,000 (1) Includes $0.20 per unit sold in the base offering, or
• $3,500,000 — per unit sold in the base offering, or $3,500,000 in the aggregate (or up to $4,025,000 i
• $4,025,000 — r $3,500,000 in the aggregate (or up to $4,025,000 if the over-allotment option is exercis
• $201,250,000 — ed in this prospectus, $175,000,000, or $201,250,000 if the underwriters' option to purchase
• $25,000 — s," "— Our sponsor paid an aggregate of $25,000, or approximately $0.003 per founder sh
• $0.003 — aggregate of $25,000, or approximately $0.003 per founder share, and, accordingly, yo
• $5,605,000 — ment unit for a total purchase price of $5,605,000 (or $5,905,000 if the underwriters' opt
• $5,905,000 — total purchase price of $5,605,000 (or $5,905,000 if the underwriters' option to purchase
• $15,000 — we will pay an affiliate of our sponsor $15,000 per month for office space, utilities a
• $10,000 — las Geeza, our Chief Financial Officer, $10,000 per month and Thomas D. Hennessy, our P
• $27,500 — idual service providers an aggregate of $27,500 per month, with discretionary annual bo
• $295,000 — annual bonuses of up to an aggregate of $295,000, for services provided in connection wi

Filing Documents

• forms-1.htm (S-1) — 2659KB
• ex3-1.htm (EX-3.1) — 518KB
• ex23-1.htm (EX-23.1) — 4KB
• ex99-1.htm (EX-99.1) — 3KB
• ex99-2.htm (EX-99.2) — 4KB
• ex99-3.htm (EX-99.3) — 4KB
• ex107.htm (EX-FILING FEES) — 38KB
• logo_001.jpg (GRAPHIC) — 6KB
• chart_001.jpg (GRAPHIC) — 836KB
• forms-1_001.jpg (GRAPHIC) — 11KB
• chart_002.jpg (GRAPHIC) — 77KB
• chart_07.jpg (GRAPHIC) — 101KB
• chart_09.jpg (GRAPHIC) — 96KB
• chart_11.jpg (GRAPHIC) — 110KB
• forms-1_002.jpg (GRAPHIC) — 11KB
• chart_006.jpg (GRAPHIC) — 83KB
• chart_08.jpg (GRAPHIC) — 100KB
• chart_10.jpg (GRAPHIC) — 96KB
• chart_12.jpg (GRAPHIC) — 111KB
• 0001493152-25-026017.txt ( ) — 9339KB
• hviii-20251203_pre.xml (EX-101.PRE) — 50KB
• hviii-20251203.xsd (EX-101.SCH) — 9KB
• hviii-20251203_def.xml (EX-101.DEF) — 17KB
• hviii-20251203_lab.xml (EX-101.LAB) — 71KB
• forms-1_htm.xml (XML) — 356KB
• ex107_htm.xml (XML) — 13KB

USE OF PROCEEDS

USE OF PROCEEDS 89 DIVIDEND POLICY 93

DILUTION

DILUTION 94 CAPITALIZATION 96

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 97 PROPOSED BUSINESS 102 MANAGEMENT 138 PRINCIPAL SHAREHOLDERS 147 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 150

DESCRIPTION OF SECURITIES

DESCRIPTION OF SECURITIES 153 TAXATION 170

UNDERWRITING

UNDERWRITING 181 LEGAL MATTERS 192 EXPERTS 192 WHERE YOU CAN FIND ADDITIONAL INFORMATION 192 Index to Financial Statements F-1 Trademarks This prospectus contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the or symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies' trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. i ii SUMMARY This summary only highlights the more detailed information appearing elsewhere in this prospectus. As this is a summary, it does not contain all of the information that you should consider in making an investment decision. You should read this entire prospectus carefully, including the information under "Risk Factors" and our financial statements and the related notes included elsewhere in this prospectus, before investing. Unless otherwise stated in this prospectus or the context otherwise requires, references to: "amended and restated memorandum and articles of association" are to our amended and restated memorandum and articles of association to be in effect upon the completion of this offering; "Companies Act" are to the Companies Act (As Revised) of the Cayman Islands as the same may be amended from time to time; "completion window" is the period following the completion of this offering at the end of which, if we have not completed our initial business combination, we will redeem 100% of the public shares at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (net of permitted withdrawals and up to $100,000 of interest

View Full Filing

View this S-1 filing on SEC EDGAR